Home > Insider Trading > Filing (0001127602-11-006181)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410233	Elizabeth Joan Miller	C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940	Svp-Pathology & Hosp. Services	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-02-15	16,678	$0.00	93,037	No	4	A	Direct
Common Stock	Disposition	2011-02-15	6,063	$56.82	86,974	No	4	D	Direct
Common Stock	Acquisiton	2011-02-15	12,259	$0.00	99,233	No	4	A	Direct
Common Stock	Acquisiton	2011-02-16	26,666	$48.74	125,899	No	4	M	Direct
Common Stock	Disposition	2011-02-16	26,666	$57.40	99,304	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	D	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Acquisiton	2011-02-15	38,000	$0.00	38,000	$56.82
Common Stock	Stock Options (Right to Buy)	Disposition	2011-02-16	26,666	$0.00	26,666	$48.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
38,000		2021-02-15	No	4	A	Direct
0		2012-02-22	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,653	Indirect	401(k)/SDCP

Footnotes

The options vested in three installments beginning with the first on February 22, 2006, the second on February 22, 2007 and the final on February 22, 2008.
The option vests in three equal annual installments beginning on the first annual anniversary of the grant date.
Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated March 4, 2008, approved in accordance with the requirements of Rule 16b-3(d).
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
Represents an award of restricted share units granted on February 15, 2011.
The amount includes exempt purchases made under the Company's stock purchase plan.
The amount includes approximately 71 shares acquired via dividend reinvestment during 2010 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company stock as of that date.